Search Results - "Zaghrini, Christelle"
-
1
High-Dose Rituximab and Early Remission in PLA2R1-Related Membranous Nephropathy
Published in Clinical journal of the American Society of Nephrology (07-08-2019)“…Different rituximab protocols are used to treat membranous nephropathy. We compared two rituximab protocols in patients with membranous nephropathy…”
Get full text
Journal Article -
2
Altered glycosylation of IgG4 promotes lectin complement pathway activation in anti-PLA2R1-associated membranous nephropathy
Published in The Journal of clinical investigation (01-03-2021)“…Primary membranous nephropathy (pMN) is a leading cause of nephrotic syndrome in adults. In most cases, this autoimmune kidney disease is associated with…”
Get full text
Journal Article -
3
Multi-Autoantibody Signature and Clinical Outcome in Membranous Nephropathy
Published in Clinical journal of the American Society of Nephrology (07-12-2020)“…Patients with membranous nephropathy can have circulating autoantibodies against membrane-bound (phospholipase A2 receptor 1 [PLA2R1] and thrombospondin type-1…”
Get full text
Journal Article -
4
Phospholipase A2 Receptor 1 Epitope Spreading at Baseline Predicts Reduced Likelihood of Remission of Membranous Nephropathy
Published in Journal of the American Society of Nephrology (01-02-2018)“…The phospholipase A2 receptor (PLA2R1) is the major autoantigen in primary membranous nephropathy. Several PLA2R1 epitopes have been characterized, and a…”
Get full text
Journal Article -
5
Ectodomain shedding of PLA2R1 is mediated by the metalloproteases ADAM10 and ADAM17
Published in The Journal of biological chemistry (01-07-2024)Get full text
Journal Article -
6
Ectodomain shedding of PLA2R1 is mediated by the metalloproteases ADAM10 and ADAM17
Published in The Journal of biological chemistry (01-07-2024)“…Phospholipase A2 receptor 1 (PLA2R1) is a 180-kDa transmembrane protein that plays a role in inflammation and cancer and is the major autoantigen in membranous…”
Get full text
Journal Article -
7
Ectodomain shedding of PLA2R1 is mediated by the metalloproteases ADAM10 and ADAM17
Published in The Journal of biological chemistry (2024)“…Phospholipase A2 receptor 1 (PLA2R1) is a 180-kDa transmembrane protein that plays a role in inflammation and cancer and is the major autoantigen in membranous…”
Get full text
Journal Article -
8
Novel ELISA for thrombospondin type 1 domain-containing 7A autoantibodies in membranous nephropathy
Published in Kidney international (01-03-2019)“…Autoantibodies against phospholipase A2 receptor 1 (PLA2R1) and thrombospondin type 1 domain-containing 7A (THSD7A) are emerging as biomarkers to classify…”
Get more information
Journal Article -
9
Altered glycosylation of IgG4 promotes lectin complement pathway activation in anti-PLA2R1–associated membranous nephropathy
Published in The Journal of clinical investigation (01-03-2021)“…Primary membranous nephropathy (pMN) is a leading cause of nephrotic syndrome in adults. In most cases, this autoimmune kidney disease is associated with…”
Get full text
Journal Article -
10
FP196NOVEL ELISA FOR THSD7A AUTOANTIBODIES IN MEMBRANOUS NEPHROPATHY
Published in Nephrology, dialysis, transplantation (01-06-2019)Get full text
Journal Article -
11
SaO027FROM NEW EPITOPE IDENTIFICATION TO PERSONALIZED MEDICINE IN PLA2R1-RELATED MEMBRANOUS NEPHROPATHY
Published in Nephrology, dialysis, transplantation (01-06-2019)Get full text
Journal Article